Universitätsklinikum Würzburg

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells (2019) Mestermann K, Giavridis T, Weber J, Rydzek J, Frenz S, Nerreter T, Mades A, et al. Journal article Exploration of artificial intelligence use with ARIES in multiple myeloma research (2019) Loda S, Krebs J, Danhof S, Schreder M, Solimando AG, Strifler S, Rasche L, et al. Journal article Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension (2019) Bringhen S, Milan A, D'Agostino M, Ferri C, Waesch R, Gay F, Larocca A, et al. Journal article Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 (2019) Hofheinz R, Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al. Conference contribution Novel diagnostic approach and algorithm for small fiber neuropathy (2019) Saffer N, Kress L, Eggermann K, Namer B, Malzacher T, Klitsch A, Kampik D, et al. Conference contribution Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension (2019) Haeusler KG, Huttner H, Kuramatsu J Journal article, Note Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease (2019) Weigand I, Knobloch L, Flitsch J, Saeger W, Monoranu CM, Höfner K, Herterich S, et al. Journal article Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice (2019) Volz J, Mammadova-Bach E, Gil-Pulido J, Nandigama R, Remer K, Sorokin L, Zernecke A, et al. Journal article Clinical approach to the patient in critical state following immunotherapy and/or stem cell transplantation: Guideline for the on-call physician (2019) Constantinescu C, Bodolea C, Pasca S, Teodorescu P, Dima D, Rus I, Tat T, et al. Journal article, Review article Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11 (2019) Duell J, Lukic DS, Karg M, Reusch U, Koch J, Zhukovsky EA, Rajkovic E, et al. Journal article